681 related articles for article (PubMed ID: 18462781)
1. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
[TBL] [Abstract][Full Text] [Related]
2. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
Ruffatti A; Tonello M; Del Ross T; Cavazzana A; Grava C; Noventa F; Tona F; Iliceto S; Pengo V
Thromb Haemost; 2006 Sep; 96(3):337-41. PubMed ID: 16953276
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome: critical analysis of the diagnostic path.
Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
6. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Ruffatti A; Tonello M; Visentin MS; Bontadi A; Hoxha A; De Carolis S; Botta A; Salvi S; Nuzzo M; Rovere-Querini P; Canti V; Mosca M; Mitic G; Bertero MT; Pengo V; Boffa MC; Tincani A
Rheumatology (Oxford); 2011 Sep; 50(9):1684-9. PubMed ID: 21652586
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
Gris JC; Quéré I; Sanmarco M; Boutiere B; Mercier E; Amiral J; Hubert AM; Ripart-Neveu S; Hoffet M; Tailland ML; Rousseau O; Monpeyroux F; Dauzat M; Sampol J; Daures JP; Berlan J; Marès P
Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
[TBL] [Abstract][Full Text] [Related]
9. Antibody profiles for the diagnosis of antiphospholipid syndrome.
Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
[TBL] [Abstract][Full Text] [Related]
10. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N
Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
12. Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome.
Liu XL; Xiao J; Zhu F
Acta Obstet Gynecol Scand; 2013 Feb; 92(2):234-7. PubMed ID: 23157457
[TBL] [Abstract][Full Text] [Related]
13. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome.
Oron G; Ben-Haroush A; Goldfarb R; Molad Y; Hod M; Bar J
J Matern Fetal Neonatal Med; 2011 Apr; 24(4):606-9. PubMed ID: 20874430
[TBL] [Abstract][Full Text] [Related]
15. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
Pengo V; Bison E; Ruffatti A; Iliceto S
Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Persijn L; Decavele AS; Schouwers S; Devreese K
Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
[TBL] [Abstract][Full Text] [Related]
19. A study of 75 pregnancies in patients with antiphospholipid syndrome.
Huong DL; Wechsler B; Bletry O; Vauthier-Brouzes D; Lefebvre G; Piette JC
J Rheumatol; 2001 Sep; 28(9):2025-30. PubMed ID: 11550970
[TBL] [Abstract][Full Text] [Related]
20. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
Harris EN; Pierangeli SS
Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
